200 related articles for article (PubMed ID: 30527427)
1. Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis.
Palman J; Shoop-Worrall S; Hyrich K; McDonagh JE
Best Pract Res Clin Rheumatol; 2018 Apr; 32(2):206-222. PubMed ID: 30527427
[TBL] [Abstract][Full Text] [Related]
2. Patients with juvenile idiopathic arthritis become adults: the role of transitional care.
Conti F; Pontikaki I; D'Andrea M; Ravelli A; De Benedetti F
Clin Exp Rheumatol; 2018; 36(6):1086-1094. PubMed ID: 29652654
[TBL] [Abstract][Full Text] [Related]
3. Time to diagnosis in juvenile idiopathic arthritis: a french perspective.
Aoust L; Rossi-Semerano L; Koné-Paut I; Dusser P
Orphanet J Rare Dis; 2017 Feb; 12(1):43. PubMed ID: 28241879
[TBL] [Abstract][Full Text] [Related]
4. 'Snakes & Ladders': factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis - a qualitative study.
Rapley T; May C; Smith N; Foster HE
Pediatr Rheumatol Online J; 2021 Mar; 19(1):43. PubMed ID: 33757545
[TBL] [Abstract][Full Text] [Related]
5. CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis.
McErlane F; Armitt G; Cobb J; Bailey K; Cleary G; Douglas S; Lunt L; Rashid A; Sampath S; Shoop-Worrall S; Smith N; Foster H; Thomson W
Rheumatology (Oxford); 2020 Jan; 59(1):137-145. PubMed ID: 31243450
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
[TBL] [Abstract][Full Text] [Related]
7. Transitional care in clinical networks for young people with juvenile idiopathic arthritis: current situation and challenges.
Cruikshank M; Foster HE; Stewart J; Davidson JE; Rapley T
Clin Rheumatol; 2016 Apr; 35(4):893-9. PubMed ID: 25920453
[TBL] [Abstract][Full Text] [Related]
8. Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies.
Butler S; Sculley D; Santos D; Girones X; Singh-Grewal D; Coda A
Curr Rheumatol Rep; 2024 Jun; 26(6):214-221. PubMed ID: 38466514
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Smitherman EA; Chahine RA; Bitencourt N; Rahman AKMF; Lawson EF; Chang JC;
J Rheumatol; 2023 Jan; 50(1):98-106. PubMed ID: 36109074
[TBL] [Abstract][Full Text] [Related]
10. Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis.
Munro J; Murray K; Boros C; Chaitow J; Allen RC; Akikusa J; Adib N; Piper SE; Singh-Grewal D;
J Paediatr Child Health; 2014 Sep; 50(9):663-6. PubMed ID: 25156704
[TBL] [Abstract][Full Text] [Related]
11. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
[TBL] [Abstract][Full Text] [Related]
12. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.
McErlane F; Foster HE; Armitt G; Bailey K; Cobb J; Davidson JE; Douglas S; Fell A; Friswell M; Pilkington C; Strike H; Smith N; Thomson W; Cleary G
Rheumatology (Oxford); 2018 Jan; 57(1):140-151. PubMed ID: 29069424
[TBL] [Abstract][Full Text] [Related]
13. Paediatric rheumatology practice in the UK benchmarked against the British Society for Paediatric and Adolescent Rheumatology/Arthritis and Musculoskeletal Alliance Standards of Care for juvenile idiopathic arthritis.
Kavirayani A; Foster HE;
Rheumatology (Oxford); 2013 Dec; 52(12):2203-7. PubMed ID: 24014649
[TBL] [Abstract][Full Text] [Related]
14. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
Shih YJ; Yang YH; Lin CY; Chang CL; Chiang BL
Pediatr Rheumatol Online J; 2019 Aug; 17(1):58. PubMed ID: 31443722
[TBL] [Abstract][Full Text] [Related]
15. Environmental Risk Factors and Early-Life Exposures in Juvenile Idiopathic Arthritis: A Case-Control Study.
Shenoi S; Shaffer ML; Wallace CA
Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1186-94. PubMed ID: 26618899
[TBL] [Abstract][Full Text] [Related]
16. Medical pathways of children with juvenile idiopathic arthritis before referral to pediatric rheumatology centers.
Freychet C; Lambert C; Pereira B; Stephan JL; Echaubard S; Merlin E; Chausset A
Joint Bone Spine; 2019 Nov; 86(6):739-745. PubMed ID: 31121314
[TBL] [Abstract][Full Text] [Related]
17. Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy.
Castagna I; Roszkowska AM; Alessandrello F; Oliverio GW; Tumminello G; Gallizzi R; Conti G; Aragona P
Int Ophthalmol; 2020 Feb; 40(2):335-342. PubMed ID: 31586268
[TBL] [Abstract][Full Text] [Related]
18. Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.
McErlane F; Foster HE; Carrasco R; Baildam EM; Chieng SE; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
Rheumatology (Oxford); 2016 Jul; 55(7):1225-34. PubMed ID: 27016664
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown.
Kalinina Ayuso V; Makhotkina N; van Tent-Hoeve M; de Groot-Mijnes JD; Wulffraat NM; Rothova A; de Boer JH
Surv Ophthalmol; 2014; 59(5):517-31. PubMed ID: 25130893
[TBL] [Abstract][Full Text] [Related]
20. Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
Morgan EM; Riebschleger MP; Horonjeff J; Consolaro A; Munro JE; Thornhill S; Beukelman T; Brunner HI; Creek EL; Harris JG; Horton DB; Lovell DJ; Mannion ML; Olson JC; Rahimi H; Gallo MC; Calandra S; Ravelli A; Ringold S; Shenoi S; Stinson J; Toupin-April K; Strand V; Bingham CO
J Rheumatol; 2017 Dec; 44(12):1884-1888. PubMed ID: 28811355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
